Montelukast to Prevent Liver Enzyme Rise in Dengue
Treatments studied
Part of Infections clinical trials.
This trial tests if montelukast (a common asthma and allergy medicine) can help prevent liver enzyme increases in adults hospitalized with dengue fever. It may be a good option if you have typical dengue and are not too sick.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed dengue infection (by a blood test).
- You must be admitted to the hospital.
- You cannot have serious liver damage or high liver enzymes (above 150 U/L).
- You cannot be pregnant, allergic to certain pain medicines, or have other serious health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.
This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.
This trial tests whether a medicine called emetine can help adults hospitalized with dengue. If you have a confirmed dengue infection and symptoms like fever, headache, or body aches, this study may be for you.
This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.
This trial studies whether dexamethasone (a steroid medicine) can help people with dengue infection who have warning signs and are still in the fever stage. It may help reduce complications like breathing problems, severe bleeding, or organ stress, but it is only for a specific window and situation.
This trial tests if montelukast, a common asthma medicine, can help protect the kidneys, heart, and eyes in people with type 2 diabetes. It is for those who already have some kidney damage (stage 2-3) and are taking certain blood pressure or diabetes medications.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.